X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1511) 1511
Book Review (366) 366
Publication (87) 87
Newsletter (54) 54
Book / eBook (23) 23
Book Chapter (21) 21
Conference Proceeding (9) 9
Newspaper Article (9) 9
Magazine Article (8) 8
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1225) 1225
uveitis (918) 918
humans (906) 906
ophthalmology (882) 882
male (588) 588
female (536) 536
animals (357) 357
middle aged (340) 340
adult (335) 335
inflammation (271) 271
aged (220) 220
eye diseases (208) 208
uveitis - drug therapy (185) 185
medicine & public health (180) 180
care and treatment (171) 171
retrospective studies (167) 167
adolescent (163) 163
treatment outcome (160) 160
disease (157) 157
child (156) 156
visual acuity (151) 151
surgery (149) 149
diagnosis (147) 147
immunology (147) 147
research (147) 147
abridged index medicus (142) 142
therapy (142) 142
uveitis, anterior - prevention & control (140) 140
eye (137) 137
rats (124) 124
follow-up studies (122) 122
anterior uveitis (120) 120
risk factors (120) 120
analysis (116) 116
uveitis - immunology (116) 116
patients (114) 114
uveitis - diagnosis (111) 111
health aspects (110) 110
glaucoma (107) 107
prospective studies (106) 106
uveitis - etiology (104) 104
arthritis (103) 103
immunosuppressive agents - therapeutic use (101) 101
rheumatology (101) 101
corticosteroids (95) 95
aged, 80 and over (93) 93
drug therapy (91) 91
young adult (89) 89
endotoxin-induced uveitis (87) 87
uveitis - prevention & control (87) 87
rats, inbred lew (86) 86
disease models, animal (83) 83
genetic structures (83) 83
juvenile idiopathic arthritis (82) 82
complications (80) 80
mice (79) 79
cataract (78) 78
medical research (78) 78
prognosis (78) 78
cytokines (77) 77
children (76) 76
infliximab (76) 76
rheumatoid-arthritis (76) 76
sense organs (76) 76
management (75) 75
phacoemulsification (75) 75
prevention (75) 75
glucocorticoids - therapeutic use (74) 74
review (72) 72
pharmacology & pharmacy (71) 71
uveitis - complications (71) 71
uveitis - pathology (70) 70
child, preschool (68) 68
cataracts (67) 67
prevalence (67) 67
tuberculosis (67) 67
rabbits (66) 66
uveitis, anterior - drug therapy (66) 66
autoimmune diseases - immunology (65) 65
experimental autoimmune uveoretinitis (65) 65
lens implantation, intraocular (65) 65
recurrence (65) 65
studies (64) 64
retina (63) 63
uveitis, anterior - etiology (63) 63
uveitis, anterior - chemically induced (62) 62
adalimumab (60) 60
chronic disease (60) 60
complications and side effects (60) 60
glucocorticoids - administration & dosage (59) 59
uveitis - therapy (59) 59
intraocular pressure (58) 58
postoperative complications - prevention & control (58) 58
uveitis - chemically induced (58) 58
acute anterior uveitis (57) 57
infection (56) 56
pediatrics (56) 56
drug therapy, combination (55) 55
medicine, experimental (55) 55
safety (55) 55
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1552) 1552
French (31) 31
German (20) 20
Chinese (3) 3
Korean (3) 3
Spanish (3) 3
Czech (2) 2
Russian (2) 2
Arabic (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the Rheumatic Diseases, ISSN 0003-4967, 09/2017, Volume 76, Issue 9, pp. 1515 - 1521
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2017, Volume 187, Issue 6, pp. 1327 - 1342
Alkali burns to the eye constitute a leading cause of worldwide blindness. In recent case series, corneal transplantation revealed unexpected damage to the... 
Pathology | EMERGENCY | TUMOR-NECROSIS-FACTOR | IN-VITRO | CYTOKINES | THERAPY | PROTECTION | BOSTON KERATOPROSTHESIS | ENDOTOXIN | EYE BURNS | PATHOLOGY | GLAUCOMA | Neuroprotective Agents - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Eye Burns - drug therapy | Retina - metabolism | Apoptosis - drug effects | Burns, Chemical - metabolism | Cornea - immunology | Retina - immunology | Infliximab - therapeutic use | Uveitis, Anterior - pathology | Infliximab - pharmacology | Burns, Chemical - etiology | Corneal Injuries - metabolism | Retinal Ganglion Cells - pathology | Receptors, Tumor Necrosis Factor, Type I - deficiency | Eye Burns - pathology | Corneal Injuries - etiology | Neuroprotective Agents - pharmacology | Uvea - metabolism | Disease Models, Animal | Uveitis, Anterior - prevention & control | Alkalies | Drug Evaluation, Preclinical - methods | Rabbits | Corneal Injuries - pathology | Oxidation-Reduction | Mice, Inbred C57BL | Eye Burns - etiology | Receptors, Tumor Necrosis Factor, Type I - genetics | Uveitis, Anterior - chemically induced | Receptors, Tumor Necrosis Factor, Type II - genetics | Mice, Knockout | Receptors, Tumor Necrosis Factor, Type II - deficiency | Animals | Uveitis, Anterior - metabolism | Burns, Chemical - drug therapy | Burns, Chemical - pathology | Eye Burns - metabolism | Apoptosis - physiology | Corneal Injuries - drug therapy | Retina - pathology | Sodium Hydroxide | Retina - injuries | Retinal Ganglion Cells - drug effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Hydrogen-Ion Concentration | Index Medicus | Abridged Index Medicus | Regular
Journal Article
Journal Article
Journal Article